Nautilus Biotechnology, Inc.
NASDAQ:NAUTBiotechnology
Healthcare
$2.36 +2.06%
+$0.05 today
- Market cap
- $300.60M
- Beta
- 0.75
- P/E (TTM)
- -4.9
- EPS (TTM)
- -$0.45
52W Low $0.62High $4.31
Volume 3.95M
Average 0.40M
Price history
Nautilus Biotechnology, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+6.79%
Period high
$3.95
Period low
$0.85
Latest
$2.36
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13D/A | Nov 3, 2026 | Nov 3, 2026 | |
| 10-Q | Oct 27, 2026 | Oct 27, 2026 | |
| 8-K | Oct 27, 2026 | Oct 26, 2026 | |
| EFFECT | Sep 18, 2026 | Sep 21, 2026 | |
| 424B5 | Sep 18, 2026 | Sep 18, 2026 | |
| 8-K | Sep 11, 2026 | Sep 11, 2026 | |
| SC 13D/A | Sep 11, 2026 | Sep 11, 2026 | |
| S-3 | Sep 11, 2026 | Sep 11, 2026 | |
| SC 13D/A | Aug 28, 2026 | Aug 28, 2026 | |
| SC 13D/A | Aug 14, 2026 | Aug 14, 2026 | |
| 10-Q | Jul 28, 2026 | Jul 28, 2026 | |
| 8-K | Jul 28, 2026 | Jul 27, 2026 | |
| SC 13D/A | Jun 30, 2026 | Jun 30, 2026 | |
| 4 | Jun 22, 2026 | Jun 22, 2026 | |
| 4 | Jun 22, 2026 | Jun 22, 2026 |
Competitors
Who does Nautilus Biotechnology, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about NAUT's filings, answered from its disclosures.
What is the latest NAUT filing?
The latest filing shown is SC 13D/A dated Nov 3, 2026.
How many recent filings does NAUT have?
Intrinsic Alpha currently shows 20 recent filings for NAUT.
Continue the stock analysis
Jump to another research area for this company.